Professional Documents
Culture Documents
I. Introduction :
Chronic Myelogenous Leukemia ( CML ) - Belongs to Myeloproliferative Disorders - Adult & elderly - Relatively slow clinical progression - Relatively better live expectancy than acute leukemia.
Adult & elderly Male > female Splenomegaly ( Schuffner VII / VIII ) Sometimes hepatomegaly Complaints : abd. fullness/dyspneu abdominal mass early satiety
I. ChronicPhase relatively stabil, lasting months / years II. Accelerated Phase decreased clin condition, weeks /months blood smear : increased of blast cells III. Blast Crisis Phase worsened condition & laboratory findings as an acute leukemia
Pathogenesis of CML :
Majority : Philadelphia chromosome (+) t (9:22) : resiprocal transversion of genetic material from chrom 9 to 22 (vv) new abnormal protein
Clinical pictures : adult/elderly, splenomegaly Routine blood : Hb low/normal/increased Platelet normal / increased WBC quite increased Blood smear : immature WBC ( blast cells ), intermediate (rods),mature WBC granulocytes all are increased
Increased of BM cellularity ( hypercellularity ) Common BM appearance : - erythropoiesis normal / increased - megakaryopoiesis normal / increased - granulopoiesis : hyperactive ( increased of granulocytes in all of stage of maturation )
BMA in the CML case ( hypercellularity and increased of granulocytes in all of stage of maturation)
BMA in the CML case ( hypercellularity and increased of granulocytes in all of stage of maturation)
Acute leukemia : - monotonous picture (dominated by blast cells/immature) - hiatus Leukemicus ( very little amount of intermediate form cells )
1. Glivec : ( Imatinib Mesylate ) per-oral. Can eradicate Philadelphia chrom. Very expensive 2. Myleran : ( Busulfan ) per-oral Potent & cheap, but toxic 3. Hydrea : ( Hydroxy Urea ) per-oral Fair / not expensive
4. Alpha Interferon inj : - imunomodulator & antiproliferative effect - can be given alone or simultaneously with Cytosine Arabinoside ( Cytarabin ) inj. Duration of treatment : 1 4 yr Relatively very expensive
New technic :
Peripheral Blood Stem-cell Transplantation ( PBSCT )
Advantages : - no need operating theatre - relatively simple & easy procedure - low cost - most ideally procedure (?)
Depends on : - 1. age (>60 yo) - 2. splenomegaly (>10 cm bac) - 3. blast > 3 % in blood smear or > 5 % in BM - 4. platelet > 700.000 / mm3 All above are Negative Prognosis Factors
Survival Rate : Median survival 4 yrs 10 % died in the 2nd yr Yearly after : increased by 20 %
THANK YOU